- The cause of failure to return to the pre-fracture place of residence and solution to continue medical treatment for osteoporosis following an operation for hip fracture - Periodic observation of single center
-
Tanaka M, Itoh S, Kato Y
- KMID: 2368637
- Osteoporos Sarcopenia.
- 2016 Sep;2(3):180-185.
- doi: 10.1016/j.afos.2016.06.004
The purpose of this study was to investigate the causes of failure to return to the pre-fracture place of residence at hospital discharge following an operation for a hip fracture... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study
-
Tanaka M, Nakamura Y, Itoh S, Kato Y
- KMID: 2377001
- Osteoporos Sarcopenia.
- 2017 Mar;3(1):37-44.
- doi: 10.1016/j.afos.2016.12.002
OBJECTIVES: This is an open labeled and retrospective cohort study which compared the effectiveness and safety of ibandronate (IBN) and minodronate (MIN) combined with eldecalcitol (ELD) in primary osteoporosis of... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of bisphosphonate combined with activated vitamin D in patients with aromatase inhibitor-induced osteoporosis after breast cancer operation
-
Tanaka M, Itoh S, Takeuchi Y
- KMID: 2437291
- Osteoporos Sarcopenia.
- 2018 Sep;4(3):111-117.
- doi: 10.1016/j.afos.2018.08.002
OBJECTIVES: We compared the effectiveness of bisphosphonates combined with activated vitamin D administered for therapy of aromatase inhibitor-induced osteoporosis after a breast cancer operation and primary postmenopausal osteoporosis through propensity... -
- CITED
-
- Close
- SHARE
-
- Close
